| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |